ModivCare Toekomstige groei

Future criteriumcontroles 0/6

De verwachting is dat ModivCare de winst en omzet met respectievelijk 75.3% en 5.7% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 76.4% per jaar.

Belangrijke informatie

75.3%

Groei van de winst

76.4%

Groei van de winst per aandeel

Healthcare winstgroei	20.9%
Inkomstengroei	5.7%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Good
Laatst bijgewerkt	18 Nov 2024

Recente toekomstige groei-updates

Recent updates

Investors Still Aren't Entirely Convinced By ModivCare Inc.'s (NASDAQ:MODV) Revenues Despite 26% Price Jump

Aug 31

Is ModivCare (NASDAQ:MODV) A Risky Investment?

Jul 11

ModivCare Inc. (NASDAQ:MODV) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Apr 04

ModivCare Inc. (NASDAQ:MODV) Just Reported Earnings, And Analysts Cut Their Target Price

Feb 29

Winst- en omzetgroeiprognoses

NasdaqGS:MODV - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	3,150	-33	55	N/A	3
12/31/2025	2,986	-44	45	92	6
12/31/2024	2,803	-188	-80	-12	6
9/30/2024	2,788	-183	-96	-62	N/A
6/30/2024	2,773	-161	-52	-18	N/A
3/31/2024	2,773	-223	-108	-71	N/A
12/31/2023	2,751	-204	-125	-83	N/A
9/30/2023	2,702	-206	-152	-113	N/A
6/30/2023	2,663	-230	-212	-173	N/A
3/31/2023	2,592	-36	-122	-85	N/A
12/31/2022	2,504	-32	-43	-10	N/A
9/30/2022	2,426	-56	25	58	N/A
6/30/2022	2,272	-35	40	69	N/A
3/31/2022	2,118	-25	99	124	N/A
12/31/2021	1,997	-7	166	187	N/A
9/30/2021	1,820	23	215	236	N/A
6/30/2021	1,647	66	352	370	N/A
3/31/2021	1,455	37	428	444	N/A
12/31/2020	1,369	32	336	348	N/A
9/30/2020	1,355	23	300	308	N/A
6/30/2020	1,428	-5	176	185	N/A
3/31/2020	1,509	5	50	61	N/A
12/31/2019	1,510	-9	50	61	N/A
9/30/2019	1,486	-2	14	25	N/A
6/30/2019	1,436	0	26	39	N/A
3/31/2019	1,416	7	7	21	N/A
12/31/2018	1,385	12	-10	8	N/A
9/30/2018	1,125	42	23	41	N/A
6/30/2018	1,191	45	N/A	38	N/A
3/31/2018	1,255	45	N/A	44	N/A
12/31/2017	1,318	40	N/A	55	N/A
9/30/2017	1,603	-23	N/A	33	N/A
6/30/2017	1,606	-32	N/A	13	N/A
3/31/2017	1,596	-34	N/A	43	N/A
12/31/2016	1,234	12	N/A	42	N/A
9/30/2016	1,566	-35	N/A	33	N/A
6/30/2016	1,533	-43	N/A	27	N/A
3/31/2016	1,440	-44	N/A	33	N/A
12/31/2015	1,478	-40	N/A	16	N/A
9/30/2015	1,473	10	N/A	47	N/A
6/30/2015	1,403	17	N/A	60	N/A
3/31/2015	1,267	22	N/A	63	N/A
12/31/2014	1,093	25	N/A	55	N/A
9/30/2014	1,045	16	N/A	44	N/A
6/30/2014	1,012	18	N/A	43	N/A
3/31/2014	1,131	19	N/A	33	N/A
12/31/2013	799	13	N/A	55	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachting is dat MODV de komende 3 jaar verliesgevend zal blijven.

Winst versus markt: De verwachting is dat MODV de komende 3 jaar verliesgevend zal blijven.

Hoge groeiwinsten: De verwachting is dat MODV de komende 3 jaar verliesgevend zal blijven.

Omzet versus markt: De omzet van MODV ( 5.7% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.9% per jaar).

Hoge groei-inkomsten: De omzet van MODV ( 5.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van MODV naar verwachting over 3 jaar hoog zal zijn

ModivCare Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Consensus EPS estimates fall by 10%

Price target decreased by 8.0% to US$25.00

ModivCare Inc. Affirms Financial Guidance for the Fiscal Year 2024

Price target decreased by 12% to US$34.33

Consensus EPS estimates fall by 423%

Price target decreased by 11% to US$41.67

Recent updates

Consensus EPS estimates fall by 10%

Price target decreased by 8.0% to US$25.00

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

ModivCare Inc. Affirms Financial Guidance for the Fiscal Year 2024

ModivCare Inc. to Report Q3, 2024 Results on Nov 06, 2024

Price target decreased by 12% to US$34.33

New major risk - Share price stability

Investors Still Aren't Entirely Convinced By ModivCare Inc.'s (NASDAQ:MODV) Revenues Despite 26% Price Jump

Consensus EPS estimates fall by 423%

New minor risk - Profitability

Price target decreased by 11% to US$41.67

Second quarter 2024 earnings: EPS misses analyst expectations

ModivCare Inc. to Report Q2, 2024 Results on Aug 07, 2024

Is ModivCare (NASDAQ:MODV) A Risky Investment?

ModivCare Inc. Unveils Integration Hub: Revolutionizing Access to NEMT Benefits

Consensus EPS estimates fall by 173%, revenue upgraded

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ModivCare Inc. Provides Revenue Guidance for the Year 2024

Insufficient new directors

ModivCare Inc. to Report Q1, 2024 Results on May 02, 2024

ModivCare Inc. (NASDAQ:MODV) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

ModivCare Inc. (NASDAQ:MODV) Just Reported Earnings, And Analysts Cut Their Target Price

New minor risk - Share price stability

Full year 2023 earnings: EPS misses analyst expectations

ModivCare Inc. Provides Earnings Guidance for the First Quarter and Fiscal Year 2024

ModivCare (NASDAQ:MODV) Seems To Be Using A Lot Of Debt

ModivCare Inc. to Report Q4, 2023 Results on Feb 22, 2024

Sentiment Still Eluding ModivCare Inc. (NASDAQ:MODV)

Modivcare Announces Executive Appointments

Price target increased by 7.5% to US$76.67

Is ModivCare (NASDAQ:MODV) A Risky Investment?

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

ModivCare Inc. Maintains Earnings Guidance for the Full Year 2023

Modivcare Inc. Announces Resignation of Stacy Saal from Board of Directors

ModivCare Inc. to Report Q3, 2023 Results on Nov 02, 2023

ThoroughCare, Inc. acquired Higi SH LLC from ModivCare Inc.

CEO, President recently bought US$121k worth of stock

Modivcare Appoints Henry “Enrique” Toledo as Chief People Officer

ModivCare Inc. Announces Barbara Gutierrez to Join as Chief Financial Officer, Effective from September 18, 2023

New minor risk - Share price stability

ModivCare Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's Why ModivCare (NASDAQ:MODV) Is Weighed Down By Its Debt Load

ModivCare Inc. to Report Q2, 2023 Results on Aug 03, 2023

ModivCare Inc.(NasdaqGS:MODV) dropped from Russell Small Cap Comp Value Index

Modivcare Appoints Jessica Kral as Chief Information Officer

CEO, President recently bought US$105k worth of stock

ModivCare Inc., Annual General Meeting, Jun 13, 2023

Price target decreased by 23% to US$117

ModivCare Inc. Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Is ModivCare (NASDAQ:MODV) A Risky Investment?

Is There An Opportunity With ModivCare Inc.'s (NASDAQ:MODV) 49% Undervaluation?

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

ModivCare Inc. Announces Executive Changes

ModivCare Inc. to Report Q4, 2022 Results on Feb 23, 2023

Price target decreased to US$146

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Modivcare Inc. Updates Its Earnings Guidance for the Year 2022

ModivCare Inc. Announces Appointment of L. Heath Sampson as Chief Executive Officer

ModivCare Inc. to Report Q3, 2022 Results on Nov 03, 2022

Does ModivCare (NASDAQ:MODV) Have A Healthy Balance Sheet?

ModivCare: ROIC And Continuing Value Are Narrowing - Rating It A Hold

ModivCare Announces Executive Changes

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

ModivCare Inc. Raises Revenue Guidance for the Year of 2022

Price target decreased to US$163

Daniel E. Greenleaf No Longer Serves as Member of Modivcare Inc.'s Board of Directors

Modivcare names finance boss Heath Sampson as interim CEO